{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Bacillus subtilis", "Bacteriocin", "Broad inhibition spectrum", "LC-ESI-MS/MS", "Mycobacterium smegmatis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33544157", "DateCompleted": {"Year": "2021", "Month": "06", "Day": "23"}, "DateRevised": {"Year": "2022", "Month": "02", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "02", "Day": "05"}], "Language": ["eng"], "ELocationID": ["10.1007/s00203-020-02173-7"], "Journal": {"ISSN": "1432-072X", "JournalIssue": {"Volume": "203", "Issue": "5", "PubDate": {"Year": "2021", "Month": "Jul"}}, "Title": "Archives of microbiology", "ISOAbbreviation": "Arch Microbiol"}, "ArticleTitle": "Experimental elucidation of an antimycobacterial bacteriocin produced by ethnomedicinal plant-derived Bacillus subtilis (MK733983).", "Pagination": {"StartPage": "1995", "EndPage": "2006", "MedlinePgn": "1995-2006"}, "Abstract": {"AbstractText": ["A bacteriocin from Bacillus subtilis (MK733983) originated from ethnomedicinal plant was purified using Preparative RP-HPLC. The HPLC fraction eluted with 65% acetonitrile showed the highest antimicrobial activity with Mycobacterium smegmatis as an indicator. Its specific activity and purification fold increased by 70.5% and 44%, respectively, compared to the crude bacteriocin. The bacteriocin showed stability over a wide range of pH (3.0-8.0) and preservation (- 20\u00a0\u00b0C and 4\u00a0\u00b0C), also thermal stability up to 80\u00a0\u00b0C for 20\u00a0min. Its proteinaceous nature was confirmed with complete loss of activity on its treatment with Trypsin, Proteinase K, and \u03b1-Chymotrypsin. Nevertheless, the bacteriocin retained up to 45% activity with Papainase treatment and was unaffected by salivary Amylase. It maintained\u2009~\u200995% activity on UV exposure up to 3\u00a0h and its activity was augmented by ethyl alcohol and metal ions like Fe<sup>2+</sup> and Mn<sup>2+</sup>. Most of the common organic solvents, general surfactants, preservatives, and detergents like Sulfobetaine-14, Deoxy-cholic-acid did not affect the bacteriocin's action. Its molecular weight was estimated to be 3.4KDa by LC-ESI-MS/MS analysis. The bacteriocin is non-hemolytic and exhibited a broad inhibition spectrum with standard strains of Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli and Chromobacterium violaceum with MICs ranging 0.225\u2009\u00b1\u20090.02-0.55\u2009\u00b1\u20090.05\u00a0mg/mL. Scanning Electron Microscopy showed cell annihilation with pores in cell membranes of S. aureus and P. aeruginosa treated with the bacteriocin, implicating bactericidal mode of action. These promising results suggest that the bacteriocin is significant and has wide-ranging application prospects."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Jain (Deemed To-Be) University, 18/3, 3rd Block, 9th Main Rd, Jayanagar, Bangalore, Karnataka, 560011, India."}], "LastName": "Santhi Sudha", "ForeName": "S", "Initials": "S"}, {"Identifier": ["0000-0002-5586-0636"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Jain (Deemed To-Be) University, 18/3, 3rd Block, 9th Main Rd, Jayanagar, Bangalore, Karnataka, 560011, India. v.aranganathan@jainuniversity.ac.in."}], "LastName": "Aranganathan", "ForeName": "V", "Initials": "V"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Arch Microbiol", "NlmUniqueID": "0410427", "ISSNLinking": "0302-8933"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Bacteriocins"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "isolation & purification", "metabolism", "pharmacology"], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": ["isolation & purification", "metabolism"], "DescriptorName": "Bacillus subtilis"}, {"QualifierName": ["classification", "drug effects"], "DescriptorName": "Bacteria"}, {"QualifierName": ["chemistry", "isolation & purification", "metabolism", "pharmacology"], "DescriptorName": "Bacteriocins"}, {"QualifierName": [], "DescriptorName": "Hydrogen-Ion Concentration"}, {"QualifierName": [], "DescriptorName": "Microbial Sensitivity Tests"}, {"QualifierName": [], "DescriptorName": "Molecular Weight"}, {"QualifierName": ["microbiology"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Tandem Mass Spectrometry"}, {"QualifierName": [], "DescriptorName": "Temperature"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Afsar T, Razak S, Khan MR, Mawash S, Almajwa A, Shabir M, Haq IU. Evaluation of antioxidant, anti-hemolytic and anticancer activity of various solvent extracts of Acacia hydaspica R. Parker aerial parts. BMC Complement Altern Med. 2016;16:258. doi: 10.1186/s12906-016-1240-8.", "ArticleIdList": ["10.1186/s12906-016-1240-8", "PMC4966721", "27473625"]}, {"Citation": "Agrawal P, Miryala S, Varshney U. Use of Mycobacterium smegmatis deficient in ADP ribosyl transferase as surrogate for Mycobacterium tuberculosis in drug testing and mutation analysis. PLoS ONE. 2015;10(4):e0122076. doi: 10.1371/journal.pone.0122076.", "ArticleIdList": ["10.1371/journal.pone.0122076", "PMC4395326", "25874691"]}, {"Citation": "Aguilar-P\u00e9rez C, Gracia B, Rodrigues L, Vitoria A, Cebri\u00e1n R, Deboos\u00e8re N, Song O-R, Brodin P, Maqueda M, A\u00ednsa JA. Synergy between circular bacteriocin AS-48 and ethambutol against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2018;62:e00359\u2013e418. doi: 10.1128/AAC.00359-18.", "ArticleIdList": ["10.1128/AAC.00359-18", "PMC6125546", "29987141"]}, {"Citation": "Anand TP, Bhat AW, Shouche YS, Roy U, Siddharth J, Sarma SP. Antimicrobial activity of marine bacteria associated with sponges from the waters off the coast of South East India. Microbiol Res. 2005;161(2006):252\u2013262. doi: 10.1016/j.micres.2005.09.002.", "ArticleIdList": ["10.1016/j.micres.2005.09.002", "16765842"]}, {"Citation": "Aurea AE, Tanh LC, Mai LN, Philippe D. Reverse-high performance liquid chromatography mechanism explained by polarization of stationary phase. CheM. 2011;1:62\u201379. doi: 10.5618/chem.2011.v1.n1.8.", "ArticleIdList": ["10.5618/chem.2011.v1.n1.8"]}, {"Citation": "Aurea AE, Roya S, Manolis NR, Philippe D. An alternative to trial and error methodology in solid phase extraction: an original automated solid phase extraction procedure for analyzing PAHs and PAH-derivatives in soot. RSC Adv. 2014;4:33636. doi: 10.1039/c4ra03214d.", "ArticleIdList": ["10.1039/c4ra03214d"]}, {"Citation": "Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial activity: a review. J Pharmaceut Anal. 2016;6(2):71\u201379.", "ArticleIdList": ["PMC5762448", "29403965"]}, {"Citation": "Batista JH, da Neto JFN. Chromobacterium violaceum pathogenicity: updates and insights from genome sequencing of novel chromobacterium species. Front Microbiol. 2017;8:2213. doi: 10.3389/fmicb.2017.02213.", "ArticleIdList": ["10.3389/fmicb.2017.02213", "PMC5686120", "29176969"]}, {"Citation": "Bizani D, Brandelli A. Characterization of a bacteriocin produced by a newly isolated Bacillus sp. Strain 8 A. J Appl Microbiol. 2002;93(3):512\u2013519. doi: 10.1046/j.1365-2672.2002.01720.x.", "ArticleIdList": ["10.1046/j.1365-2672.2002.01720.x", "12174052"]}, {"Citation": "Bizani D, Motta AS, Morrissy JA, Terra R, Souto AA, Brandelli A. Antibacterial activity of cerein 8A, a bacteriocin-like peptide produced by Bacillus cereus. Int Microbiol. 2005;8:125\u2013131.", "ArticleIdList": ["16052461"]}, {"Citation": "Boelaert M, Jacobs J. Fatal chromobacterium violaceum bacteraemia in rural Bandundu, Democratic Republic of the Congo. New Microbes New Infect. 2014;3:21\u201323. doi: 10.1016/j.nmni.2014.10.007.", "ArticleIdList": ["10.1016/j.nmni.2014.10.007", "PMC4337932", "25755887"]}, {"Citation": "Cita YP, Suhermanto A, Radjasa OK, Sudharmono P. Antibacterial activity of marine bacteria isolated from sponge Xestospongia testudinaria from Sorong. Papua Asian Pac J Trop Biomed. 2017;7(5):450\u2013454. doi: 10.1016/j.apjtb.2017.01.024.", "ArticleIdList": ["10.1016/j.apjtb.2017.01.024"]}, {"Citation": "Gao FH, Abee T, Konings WN. Mechanism of action of the peptide antibiotic nisin in liposomes and cytochrome c oxidase-containing proteoliposomes. Appl Environ Microbiol. 1991;57(8):2164\u20132170. doi: 10.1128/AEM.57.8.2164-2170.1991.", "ArticleIdList": ["10.1128/AEM.57.8.2164-2170.1991", "PMC183545", "1662930"]}, {"Citation": "Ge J, Sun Y, Xin X, Wang Y, Ping W. Purification and partial characterization of a novel bacteriocin synthesized by Lactobacillus paracasei HD1-7 isolated from Chinese Sauerkraut juice. Sci Rep. 2016;6:19366. doi: 10.1038/srep19366.", "ArticleIdList": ["10.1038/srep19366", "PMC4725913", "26763314"]}, {"Citation": "Gray EJ, Lee KD, Souleimanov AM, Falco MRD, Zhou X, Ly A, Charles TC, Driscoll BT, Smith DL. A novel bacteriocin, thuricin 17, produced by plant growth promoting rhizobacteria strain Bacillus thuringiensis NEB17: isolation and classification. J Appl Microbiol. 2006;100(3):545\u2013554. doi: 10.1111/j.1365-2672.2006.02822.x.", "ArticleIdList": ["10.1111/j.1365-2672.2006.02822.x", "16478494"]}, {"Citation": "Gutsmann T. Interaction between antimicrobial peptides and mycobacteria. Biochem Biophys Acta. 2016;1858:1034\u20131043. doi: 10.1016/j.bbamem.2016.01.031.", "ArticleIdList": ["10.1016/j.bbamem.2016.01.031", "26851776"]}, {"Citation": "Hammami RA, Jaouadi B, Rebai A, Nesme X. Optimization and biochemical characterization of a bacteriocin from a newly isolated Bacillus subtilis strain 14B for biocontrol of Agrobacterium spp. Strains Lett Appl Microbiol. 2009;48(2):253\u2013260. doi: 10.1111/j.1472-765X.2008.02524.x.", "ArticleIdList": ["10.1111/j.1472-765X.2008.02524.x", "19196444"]}, {"Citation": "Kassaa A, Hober I, Hamze D, Chihib NE, Drider D. Antiviral potential of lactic acid bacteria and their bacteriocins. Probiotics Antimicrob Prot. 2014;6:177\u2013185. doi: 10.1007/s12602-014-9162-6.", "ArticleIdList": ["10.1007/s12602-014-9162-6", "24880436"]}, {"Citation": "Lange-Starke A, Petereit A, Truyen U, Braun PG, Fehlhaber K, Albert T. Antiviral potential of selected starter cultures, bacteriocins and D, L-Lactic Acid. Food Environ Virol. 2014;6(1):42\u201347. doi: 10.1007/s12560-013-9135-z.", "ArticleIdList": ["10.1007/s12560-013-9135-z", "PMC7090810", "24297091"]}, {"Citation": "Le CF, Fang CM, Sekaran SD. Intracellular targeting mechanisms by antimicrobial peptides. Antimicrob Agents Chemother. 2017;61:e02340\u2013e2416. doi: 10.1128/AAC.02340-16.", "ArticleIdList": ["10.1128/AAC.02340-16", "PMC5365711", "28167546"]}, {"Citation": "Lee SG, Chang HG. Purification and characterization of mejucin, a new bacteriocin produced by Bacillus subtilis SN7. LWT Food Sci Technol. 2018;87:815. doi: 10.1016/j.lwt.2017.08.044.", "ArticleIdList": ["10.1016/j.lwt.2017.08.044"]}, {"Citation": "Li XZ, Li Z, Hiroshi N. Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis. Antimicrob Agents Chemother. 2004;48(7):2415\u20132423. doi: 10.1128/AAC.48.7.2415-2423.2004.", "ArticleIdList": ["10.1128/AAC.48.7.2415-2423.2004", "PMC434187", "15215089"]}, {"Citation": "Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265\u2013275. doi: 10.1016/S0021-9258(19)52451-6.", "ArticleIdList": ["10.1016/S0021-9258(19)52451-6", "14907713"]}, {"Citation": "Malini M, Savitha J. Heat stable bacteriocin from Lactobacillus paracasei subsp. tolerans isolated from locally available cheese: an in vitro study. J Biotechnol Pharm Res. 2012;3(2):28\u201341."}, {"Citation": "Naafs MAB. The antimicrobial peptides: ready for clinical trials? Biomed J Sci Technol Res. 2018 doi: 10.26717/BJSTR.2018.07.001536.", "ArticleIdList": ["10.26717/BJSTR.2018.07.001536"]}, {"Citation": "Park YS, Yang YJ, Kim YB, Hong JH, Lee C. Characterization of subtilein, a bacteriocin from Bacillus subtilis CAU131 (KCCM 10257) J Microbiol Biotechnol. 2002;12(2):228\u2013234."}, {"Citation": "Peng JY, Horng YB, Wu CH, Chang CY, Tsai PS, Jeng CR, Cheng YH, Chang HW. Evaluation of antiviral activity of Bacillus licheniformis-fermented products against porcine epidemic diarrhea virus. AMB Express. 2019;9(1):191. doi: 10.1186/s13568-019-0916-0.", "ArticleIdList": ["10.1186/s13568-019-0916-0", "PMC6890879", "31797149"]}, {"Citation": "Pfalzgraff A, Brandenburg K, Weindl G. Antimicrobial peptides and their therapeutic potential for bacterial skin infections and wounds. Front Pharmacol. 2018;9:281. doi: 10.3389/fphar.2018.00281.", "ArticleIdList": ["10.3389/fphar.2018.00281", "PMC5882822", "29643807"]}, {"Citation": "Ramya R, Chalasani AG, Lal R, Roy U. A broad-spectrum antimicrobial activity of Bacillus subtilis RLID 12.1. Sci World J. 2014 doi: 10.1155/2014/968487.", "ArticleIdList": ["10.1155/2014/968487", "PMC4144302", "25180214"]}, {"Citation": "Santhi SS, Aranganathan V. Bioprospecting of some ethnomedicinal plants for potential antimycobacterial bacteriocin like inhibitory substances (BLIS) Explor Anim Med Res. 2019;9(2):180\u2013187."}, {"Citation": "Sharma G, Dang S, Gupta S, Gabrani R. Antibacterial activity, cytotoxicity, and the mechanism of action of bacteriocin from Bacillus subtilis GAS101. Med Princ Pract. 2018;27(2):186\u2013192. doi: 10.1159/000487306.", "ArticleIdList": ["10.1159/000487306", "PMC5968280", "29402863"]}, {"Citation": "Silva DS, Castro CC, Silva FS, Santanna V, Vargas GD, Lima MD, Fischer G, Brandelli A, Motta AS, H\u00fcbner SO. Antiviral activity of a Bacillus sp. P34 peptide against pathogenic viruses of domestic animals. Braz J Microbiol. 2014;45(3):1089\u20131094. doi: 10.1590/S1517-83822014000300043.", "ArticleIdList": ["10.1590/S1517-83822014000300043", "PMC4204951", "25477947"]}, {"Citation": "Sivaraj A, Sundar R, Manikkam R, Parthasarathy K, Rani U, Vanaja K. Potential applications of lactic acid bacteria and bacteriocins in antimycobacterial therapy. Asian Pac J Trop Med. 2018;11(8):453\u2013459. doi: 10.4103/1995-7645.240080.", "ArticleIdList": ["10.4103/1995-7645.240080"]}, {"Citation": "Sohail M, Sultana Q, Rasool K, Sarwar S, Basit A, Khalid M. Bacteremia prediction by inflammatory factors and recent trend in drug resistance of bacteria isolated from blood stream infection. J Inf Mol Biol. 2015;3(3):75\u201380. doi: 10.14737/journal.jimb/2015/3.3.75.80.", "ArticleIdList": ["10.14737/journal.jimb/2015/3.3.75.80"]}, {"Citation": "Sosunov V, Mischenko V, Eruslanov B, Svetoch E, Shakina Y, Stern N, Majorov K, Sorokoumova G, Selishcheva A, Apt A. Antimycobacterial activity of bacteriocins and their complexes with liposomes. J Antimicrob Chemother. 2007;59(5):919\u2013925. doi: 10.1093/jac/dkm053.", "ArticleIdList": ["10.1093/jac/dkm053", "17347179"]}, {"Citation": "Soto PF (2014) Purification and characterization of an antimicrobial peptide produced by Bacillus sp. strain P7. Dissertation, University of Manchester."}, {"Citation": "Starosila D, Rybalko S, Varbanetz L, Ivanskaya N, Sorokulova I. Anti-influenza activity of a Bacillus subtilis probiotic strain. Antimicrob Agents Chemother. 2017;61:e00539\u2013e617. doi: 10.1128/AAC.00539-17.", "ArticleIdList": ["10.1128/AAC.00539-17", "PMC5487639", "28416546"]}, {"Citation": "Tagg JR, McGiven AR. Assay system for bacteriocins. Appl Microbiol. 1971;21(5):943. doi: 10.1128/am.21.5.943-943.1971.", "ArticleIdList": ["10.1128/am.21.5.943-943.1971", "PMC377313", "4930039"]}, {"Citation": "Tiberi S, Mu\u00f1oz-Torrico M, Duarte R, Dalcolmo M, D'Ambrosio L. Migliori GB (2017) New drugs and perspectives for new anti-tuberculosis regimens. Pulmonology. 2018;24(2):86\u201398. doi: 10.1016/j.rppnen.10.009.", "ArticleIdList": ["10.1016/j.rppnen.10.009", "29487031"]}, {"Citation": "Wang X, Hu W, Zhu L, Yang Q. Bacillus subtilis and surfactin inhibit the transmissible gastroenteritis virus from entering the intestinal epithelial cells. Biosci Rep. 2017;37(2):BSR20170082. doi: 10.1042/BSR20170082.", "ArticleIdList": ["10.1042/BSR20170082", "PMC5469330", "28270576"]}, {"Citation": "WHO (2017) Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline, including tuberculosis. Geneva: World Health Organization (WHO/EMP/IAU/2017.12). Licence: CC BY-NC-SA 3.0 IGO.CIP data are available at http://apps.who.int/iris. Accessed 20 Feb 2018"}, {"Citation": "WHO (2020) Report https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance. Accessed 31 July 2020"}, {"Citation": "Wolcott RD, Ehrlich GD. Biofilms and chronic infections. JAMA. 2008;299(22):2682\u20132684. doi: 10.1001/jama.299.22.2682.", "ArticleIdList": ["10.1001/jama.299.22.2682", "18544729"]}, {"Citation": "Wu J, Abbas HMK, Li J, Yuan Y, Liu Y, Wang G, Dong W. Cell membrane-interrupting antimicrobial peptides from Isatis indigotica fortune isolated by a Bacillus subtilis expression system. Biomolecules. 2020 doi: 10.3390/biom10010030.", "ArticleIdList": ["10.3390/biom10010030", "PMC7023251", "31878275"]}, {"Citation": "Zhang J, Yang Y, Yang H, Bu Y, Yi H, Zhang L, Han X, Ai L. Purification and partial characterization of bacteriocin Lac-B23, a novel bacteriocin production by Lactobacillus plantarum J23, isolated from Chinese traditional fermented milk. Front Microbiol. 2018;9:2165. doi: 10.3389/fmicb.2018.02165.", "ArticleIdList": ["10.3389/fmicb.2018.02165", "PMC6174205", "30327641"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "8", "Day": "22"}, {"Year": "2020", "Month": "12", "Day": "27"}, {"Year": "2020", "Month": "11", "Day": "24"}, {"Year": "2021", "Month": "2", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "2", "Day": "5", "Hour": "12", "Minute": "12"}, {"Year": "2021", "Month": "2", "Day": "5"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33544157", "PMC7863612", "10.1007/s00203-020-02173-7", "10.1007/s00203-020-02173-7"]}}], "PubmedBookArticle": []}